New Zealand markets close in 3 hours

Qingdao Vland Biotech INC. (603739.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
12.84-0.07 (-0.54%)
As of 09:45AM CST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,253,129
1,198,902
1,163,163
1,150,824
960,249
Cost of revenue
673,292
644,687
660,311
618,507
492,334
Gross profit
579,837
554,215
502,852
532,316
467,915
Operating expenses
Research development
114,739
110,682
102,397
100,937
79,913
Selling general and administrative
229,787
220,499
210,395
210,328
188,236
Total operating expenses
425,930
412,908
377,511
356,267
318,245
Operating income or loss
153,908
141,307
125,341
176,049
149,671
Interest expense
18,016
15,218
7,172
2,123
1,776
Income before tax
130,531
122,495
102,187
171,403
140,149
Income tax expense
23,064
19,638
16,776
21,306
17,844
Income from continuing operations
107,468
102,857
85,411
150,097
122,305
Net income
82,867
80,707
69,842
132,573
108,976
Net income available to common shareholders
82,867
80,707
69,842
132,573
108,976
Basic EPS
0.28
0.32
0.28
0.54
0.48
Diluted EPS
0.27
0.32
0.27
0.54
0.48
Basic average shares
253,222
252,209
249,436
245,506
227,034
Diluted average shares
262,460
252,209
258,674
245,506
227,034